Traitement médical de l'insuffisance cardiaque aiguë décompensée

Zannad, 2002, Clinical and etiological features, management and outcomes of acute heart failure: the EFICA cohort study, Eur Heat J, 23, 579 Adams, 1998, Clinical definition and epidemiology of advanced heart failure, Am Heart J, 135, S204, 10.1016/S0002-8703(98)70251-0 1997, Ambulatory intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial, J Am Coll Cardiol, 326A Dries, 1986, Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure, Circulation, 74, 326 A Packer, 1991, Effect of oral milrinone on mortality in severe chronic heart failure, N Engl J Med, 325, 1468, 10.1056/NEJM199111213252103 Bersten, 1991, Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask, N Engl J Med, 325, 1825, 10.1056/NEJM199112263252601 Pinsky, 1988, The effect of intrathoracic pressure on the failing heart, 325 Naughton, 1995, Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure, Circulation, 91, 1725, 10.1161/01.CIR.91.6.1725 Lin, 1995, Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up, Chest, 107, 1379, 10.1378/chest.107.5.1379 Rasanen, 1985, Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema, Am J Cardiol, 55, 296, 10.1016/0002-9149(85)90364-9 Pang, 1998, The effect of positive airway support on mortality and the need for intubation in acute cardiogenic pulmonary edema, Chest, 114, 1185, 10.1378/chest.114.4.1185 Masip, 2000, Non invasive pressure support ventilation vs conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomized trial, Lancet, 356, 2126, 10.1016/S0140-6736(00)03492-9 Sharon, 2000, High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema, J Am Coll Cardiol, 36, 832, 10.1016/S0735-1097(00)00785-3 Mehta, 1997, Randomized, prospective trial of bilevel vs continuous positive airway pressure in acute pulmonary edema, Crit Care Med, 25, 620, 10.1097/00003246-199704000-00011 Panacek, 2002, Role of non-invasive ventilation in the management of acutely decompensated heart failure, Rev Cardiovasc Med, 3, S35 Dikshit, 1973, Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after myocardial infarction, N Engl J Med, 288, 1087, 10.1056/NEJM197305242882102 Dormans, 1996, Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection vs continuous infusion, J Am Coll Cardiol, 28, 376, 10.1016/S0735-1097(96)00161-1 Aaser, 1997, Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure, Scand J Clin Lab Invest, 57, 361, 10.3109/00365519709099409 Northridge, 1996, Frusemide or nitrates for acute heart failure, Lancet, 347, 667, 10.1016/S0140-6736(96)91209-X Cotter, 1998, Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide vs high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary edema, Lancet, 351, 389, 10.1016/S0140-6736(97)08417-1 2002, Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure. A randomized trial, Jama, 287, 1531 Colucci, 2000, Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure, N Engl J Med, 343, 246, 10.1056/NEJM200007273430403 Monrad, 1986, Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure, Circulation, 73, III168 Bristow, 2001, Inotropes and beta-blockers: is there a need for new guidelines?, J Card Fail, 7, 8, 10.1054/jcaf.2001.26655 Lowes, 2001, Milrinone vs dobutamine in heart failure subjects treated chronically with carvedilol, Int J Cardiol, 81, 141, 10.1016/S0167-5273(01)00520-4 O'Connor, 1999, Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST), Am Heart J, 138, 78, 10.1016/S0002-8703(99)70250-4 Follath, 2002, Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial, Lancet, 360, 196, 10.1016/S0140-6736(02)09455-2 Thackray, 2002, The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis, Eur J Heart Fail, 4, 515, 10.1016/S1388-9842(02)00041-7 Stevenson, 2003, Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization, Circulation, 108, 367, 10.1161/01.CIR.0000078348.44634.BA Goldberg, 1972, Cardiovascular and renal actions of dopamine: potential clinical applications, Pharmacol Rev, 24, 1 Beregovitch, 1974, Dose-related hemodynamic and renal effects of dopamine in congestive heart failure, Am Heart J, 87, 550, 10.1016/0002-8703(74)90491-8 Bellomo, 2000, Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial, Lancet, 356, 2139, 10.1016/S0140-6736(00)03495-4 Galley, 2000, Renal-dose dopamine: will the message now get through?, Lancet, 356, 2112, 10.1016/S0140-6736(00)03484-X Maskin, 1985, Comparative systemic and renal effects of dopamine and angiotensin-converting enzyme inhibition with enalaprilat in patients with heart failure, Circulation, 72, 846, 10.1161/01.CIR.72.4.846 Loh, 2001, A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure, J Card Fail, 7, 114, 10.1054/jcaf.2001.24136 Cuffe, 2002, Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial, Jama, 287, 1541, 10.1001/jama.287.12.1541 Leier, 1988, Cardiovascular pharmacology of dopexamine in low output congestive heart failure, Am J Cardiol, 62, 94, 10.1016/0002-9149(88)91371-9 Figgitt, 2001, Levosimendan, Drugs, 61, 613, 10.2165/00003495-200161050-00006 Kivikko, 2003, Sustained hemodynamic effects of intravenous levosimendan, Circulation, 107, 81, 10.1161/01.CIR.0000043245.00859.11 Maisel, 2002, Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure, N Engl J Med, 347, 161, 10.1056/NEJMoa020233 Kelly, 1990, Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery, Eur Heart J, 11, 138, 10.1093/oxfordjournals.eurheartj.a059669 Monrad, 1986, Milrinone, dobutamine and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure, Circulation, 73, III-168